| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.0007 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0009 |